Integrated Biomaterial & Cell Technologies S.r.l. – Trademark Portfolio

Entity Type: 16

Integrated Biomaterial & Cell Technologies S.r.l. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. The owner is based in 40128 Bologna (BO).

Via Aposazza, 2

40128 Bologna (BO) , IT

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Integrated Biomaterial & Cell Technologies S.r.l.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Integrated Biomaterial & Cell Technologies S.r.l. have?

Integrated Biomaterial & Cell Technologies S.r.l. has 1 U.S. trademark filed with the USPTO.

What trademark classes does Integrated Biomaterial & Cell Technologies S.r.l. file in?

Integrated Biomaterial & Cell Technologies S.r.l. files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What is Integrated Biomaterial & Cell Technologies S.r.l.'s trademark registration success rate?

Integrated Biomaterial & Cell Technologies S.r.l. has a 0% trademark registration rate, with 0 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.